<i>B. bassiana</i> decreased longevity and impaired climbing. by Deepanshu N. D. Singh (20721878)

Nesfatin-1 decreased excitability of GI-neurons in DVC. by Jing Dong (102657)

PSD-95 decreased ASIC2a acid-evoked current. by Anne Marie S. Harding (546425)

TGF-β1 decreases RECK expression in fibroblasts. by Jaime Gutiérrez (401710)

<i>Zip88E</i>^<i>Δ/Δ</i> larvae have decreased <i>MtnB</i>:<i>EYFP</i> expression. by Christopher D. Richards (4246669)

“…<p>A, B, D, E) <i>MtnB</i>:<i>EYFP</i> expression in third instar larval midguts from control and <i>Zip88E</i>^<i>Δ/Δ</i> homozygous larvae on basal medium (A and B) and after exposure to 2 mmol l^-1 ZnCl₂-supplemented medium (D, E). …”

The M77K mutation decreases the calcium-induced activation of Nox5. by Yusi Wang (592335)

Decreased TORC1 activates HPK-1 to extend longevity. by Ritika Das (4514968)

“…<p>(A-D) Decreased TORC1 induces neuronal expression of HPK-1. …”

RNA interference-mediated decrease in Ixofin3D results in decreased <i>B. burgdorferi</i> burden in the salivary glands and in murine skin. by Sukanya Narasimhan (73432)

Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

“…Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively.…”

CONSORT flow diagram. by Judith I. Tsui (5983160)

“…Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively.…”

Adverse events in placebo arm. by Judith I. Tsui (5983160)

“…Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively.…”

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

“…Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively.…”

Bone mass and formation are decreased in Akt1-/- mice. by Naohiro Kawamura (33999)

CD11b and TLR-5 expression are decreased on CF macrophage membrane. by Karin Simonin-Le Jeune (464354)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

FRAT1 depletion decreases tumorigenicity in nude mice. by Geng Guo (403691)

Decreased <i>S</i>. <i>epidermidis</i> biofilm formation on immobilized proteins MBP-QQ-5 and MBP-QQ-7. by Nancy Weiland-Bräuer (5581526)

Inhibition of NLRP3 inflammasomes decreased 5-FU-induced cell death. by Kaya Yoshida (658943)

Homozygous deletion of <i>ERG251</i> leads to the decreased ergosterol accumulation in the absence of FLC and decreased production of toxic dienol in the presence of FLC. by Xin Zhou (54275)